Registration - Consultant

BAXTER CORP. / CARL BALTARE, Consultant

Registration Information

Client name: BAXTER CORP.
Lobbyist name: CARL BALTARE, Consultant
Initial registration start date: 2004-09-14
Registration status: Inactive
Registration Number: 776307-2439

Associated Communications

Total Number of Communication Reports: 16

Monthly communication reports in the last 6 months: 0

Version 8 of 10 (2013-12-16 to 2015-04-29)

Registration versions:

Version 8 of 10 (2013-12-16 to 2015-04-29)

Lobbying Information

Subject Matters

Consumer Issues
Economic Development
Environment
Health
Industry
Intellectual Property
International Trade
Justice and Law Enforcement
Regional Development
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution

Private members' business (formerly Bill C-307) - Environment and Sustainable Development (ENVI) with respect to prohibit the use of Bis (2-ETHYLHEXYL) Phthalate, Benzyl Butyl Phthalate and Dibutyl Phthalate

Legislative Proposal, Bill or Resolution, Policies or Program

Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to consumer products
Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to therapeutic products

Policies or Program

Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
Health Canada Blueprint for Renewal: Modernizing Regulatory System for Health Products and Food (formerly Bill C-51)
Influenza/Pandemic Preparedness plans and programs with repsect to international collaboration on pandemic preparedness planning
Influenza/Pandemic Preparedness plans and programs with respect to procurement and stockpiling of therapeutic products to address pandemic influenza
Influenza/Pandemic Preparedness plans and programs with respect to the Canadian Pandemic Influenza Plan for the Health Sector
International Trade Canada's Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector
Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy

Policies or Program, Regulation

Canadian Environmental Protection Act Regulations with regard to the regulation of chemicals and toxic substances, specifically Bisphenol A, Bis ( 2-ETHYLHEXYL) Phthalate, Benzyl Butyl Phthalate and Dibutyl Phthalate
Canadian Environmental Protection Act as it relates to the regulation of chemicals and toxic substances, specficially Bisphenol A, Bis ( 2-ETHYLHEXYL) Phthalate, Benzyl Butyl Phthalate and Dibutyl Phthalate
Federal Chemicals Management Plan as it relates to the regulation of chemicals and toxic substances, specifically Bisphenol A
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
Health Canada policies on regulatory and legislative proposals on Subsequent Entry Biologics with respect to guidance for sponsors
Health Canada policies on regulatory and legislative proposals on Subsequent Entry Biologics with respect to a draft regulatory pathway and guidelines
Health Canada policies with respect to Subsequent Entry Biologics
Patent Act as it relates to the regulation of intellectual property for therapeutic products
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)

Regulation

Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
Food and Drugs Act Regulations, specficially with respect to approval, regulation and life-cycle management of therapeutic products
Medical Devices Regulations under the Food and Drugs Act, specifically with respect to the approval, regulation and life cycle management of medical devices
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Environment Canada
Federal Economic Development Agency for Southern Ontario (FedDev)
Federal Environmental Assessment Review Office (FEARO)
Finance Canada (FIN)
Foreign Affairs, Trade and Development Canada
Hazardous Materials Information Review Commission (HMIRC)
Health Canada (HC)
House of Commons
Industry Canada
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
4 ROBERT SPECK PARKWAY, SUITE 700
MISSISSAUGA, ON L4Z 3Y4
Canada

Telephone number: 905-281-6489
Fax number: 905-281-6570

Client representative

Saurabh Popat, Director, Government Affairs & Public Policy

Parent Company Information

BAXTER
- ONE BAXTER PARKWAY
  DEERFIELD, IL 60015
  United States of America

Coalition Members Information

BAXTER CORP. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of BAXTER CORP. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

BAXTER CORP. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

CARL BALTARE | Public offices held

Business address:
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON K1P 6L2
Canada

Telephone number: 613-783-3438
Fax number: 613-782-2426

Consultant Firm and Address

Firm: GLOBAL PUBLIC AFFAIRS

Address:
50 O'CONNOR ST. SUITE 901
OTTAWA, ON K1P 6L2
Canada

Telephone number: 613-783-3438
Fax number: 613-782-2426

BAXTER CORP.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
BAXTER CORP.	2008-08-07	2016-12-31

The following names have been used before July 2, 2008

BAXTER CORP.
BAXTER CORP.

BAXTER CORP.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Intern Department of Public Works, Electronic Data Processing Procurement	May 1974 to August 1974	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Intern Department of Public Works, Electronic Data Processing Procurement	May 1974 to August 1974	Not a designated office

Date Modified:: 2025-03-12

Search and menus

Language selection

Registration - Consultant

BAXTER CORP. / CARL BALTARE, Consultant

Registration Information

Associated Communications

Version 8 of 10 (2013-12-16 to 2015-04-29)

Version 8 of 10 (2013-12-16 to 2015-04-29)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Bill or Resolution, Policies or Program

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address